Navigation Links
ISS Recommends That WuXi Shareholders Vote for Proposed Combination With Charles River
Date:7/27/2010

Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward- looking statements may be identified by the use of words such as "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These statements are based on current expectations and beliefs of WuXi PharmaTech (Cayman) Inc. ("WuXi"), and involve a number of risks and uncertainties that could cause actual results to differ materially from those stated or implied by the forward- looking statements. Those risks and uncertainties include, but are not limited to: 1) the possibility that the proposed combination may be delayed or not completed due to the failure to obtain stockholder or regulatory approvals or otherwise satisfy the conditions to the proposed combination as set forth in the acquisition agreement for the proposed combination; 2) problems may arise in successfully integrating the businesses of the two companies (including retention of key executives); 3) the acquisition may involve unexpected costs; 4) the combined company may be unable to achieve the expected transaction benefits, including improved customer service levels and anticipated cost and revenue synergies, or achieve potential revenue growth and non-GAAP margin expansion; 5) the businesses may suffer as a result of uncertainty surrounding the acquisition; and 6) the industry may be subject to future regulatory or legislative actions and other risks that are described in Securities and Exchange Commission ("SEC") reports filed or furnished by WuXi. For additional information on these and other important factors that could adversely affect Wuxi's business, financial condition, results of operations and prospects, see "Risk Factors" beginni
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
2. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
3. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
4. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
5. Task Force Recommends Screening for Hearing Loss in All Newborns
6. CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
7. Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
8. CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors
9. Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial
10. Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms
11. FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... YORK , May 22, 2013 ... investigating potential claims on behalf of purchasers of ... the "Company") (NasdaqGS: AMAG -News).  The investigation focuses ... federal securities laws. On May 22, ... during intraday trading after the company announced in ...
(Date:5/22/2013)... WHITE PLAINS, N.Y. , May 22, 2013 /PRNewswire/ ... $6 million to Valor Biotherapeutics, LLC, a ... completion of pre-clinical development, manufacturing, and a Phase I ... change the poor outcomes faced by many patients with ... with rituximab. Valor,s protein, IGN002, is ...
(Date:5/22/2013)... NEW YORK , May 22, 2013  The ... international conference devoted to advancing new treatments for lupus ... to 60 percent of patients. The conference launched a ... – the Lupus Nephritis Trials Network (LNTN). ... lupus and the kidney came together to focus on ...
Breaking Medicine Technology:Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis 2
... N.J., Sept. 29 Sparta Systems, Inc. ... software and the market leader in enterprise ... Qualitest Pharmaceuticals , a top-six provider of ... streamline multiple quality and compliance processes.   ...
... China, Sept. 29 /PRNewswire-Asia-FirstCall/ -- ... ... var ... by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
Cached Medicine Technology:Qualitest Pharmaceuticals Selects TrackWise® for Comprehensive Enterprise Quality and Document Management 2Qualitest Pharmaceuticals Selects TrackWise® for Comprehensive Enterprise Quality and Document Management 3Qualitest Pharmaceuticals Selects TrackWise® for Comprehensive Enterprise Quality and Document Management 4Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 2Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 3Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 4Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 5Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 6Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 7Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 8Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010 9
(Date:5/22/2013)... Researchers in genomic health disparities from the University ... University School of Medicine have teamed up to hold ... Eliminate Health Disparities in Genomic Medicine." The theme ... nonprofits, business and government to reduce these disparities. , ... United States, individuals within underserved groups continue to be ...
(Date:5/22/2013)... By Maureen Salamon HealthDay Reporter , , WEDNESDAY, ... each cause a great deal of suffering, but new ... linked to something else entirely -- a smaller brain. ... double the risk of depression, scientists wanted to determine ... The difference in size -- about 2 percent -- ...
(Date:5/22/2013)... 22, 2013 Award Presented at the ... press release here: http://bit.ly/13DkFfk , Merrill Corporation ... “Information Management Product/Service of the Year” at the 7th ... The Colony Hotel in Palm Beach, Florida. , ... room (VDR) solution that optimizes the due diligence ...
(Date:5/22/2013)... May 22, 2013 Recent tragedies ... and the school shooting in Newtown, Connecticut all ... , Emergency medical practitioners train to ... the Emergency Medical Services for Children (EMSC) Program ... care for the youngest patients. It is estimated ...
(Date:5/22/2013)... Registered Dietitian and Founder of Tatalou Science ... sharing a recipe for making energy bars at home. , ... ,” takes a recipe modified from one recently featured ... day it gets more and more difficult to understand what ... size of the nutrition label continues to grow and consumers ...
Breaking Medicine News(10 mins):Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 3Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3Health News:When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care 2Health News:How To "Make Your Own Healthy Energy Bars" 2
... FRIDAY, Oct. 1 (HealthDay News) -- A good night,s ... levels normal, new research suggests. Pregnant women who got ... had systolic blood pressure readings in their last trimester that ... hours nightly, the study found. And women who got less ...
... 1, 2010 A UC Irvine infectious disease specialist has ... of new methods to prevent staph infections in people who ... The federal Agency for Healthcare Research & Quality awarded Huang ... funded by American Recovery & Reinvestment Act of 2009. CHOICE ...
... (Oct.. 1, 2010)"It,s Your Game: Keep It Real," an evidence-based ... Texas Health Science Center at Houston (UTHealth), will be implemented ... part of a federally-funded program to tackle the U.S. teenage ... Human Services (HHS) awarded $15 million of its $155-million total ...
... a University of California, Berkeley, researcher could give women a ... study suggests that women who get dental care reduce their ... at least one-third. The analysis, which used data ... and Retirement Study, did not find a similar benefit for ...
... , THURSDAY, Sept. 30 (HealthDay News) -- New research finds ... soon as levels of a biomarker for the cancer rise ... begin to reappear. Blood levels of the marker, known ... ovarian cancer relapse, but there has been some debate on ...
... of the journal Sleep found that getting too little ... blood pressure in the third trimester. The study suggests that ... show that the mean systolic blood pressure in the third trimester ... sleep duration of nine hours in early pregnancy, 118.05 mm Hg ...
Cached Medicine News:Health News:Lack of Sleep During Pregnancy Ups Risk of High Blood Pressure 2Health News:Lack of Sleep During Pregnancy Ups Risk of High Blood Pressure 3Health News:UCI gets major funding to study ways of preventing drug-resistant staph infections 2Health News:UTHealth researchers awarded $15 million for teen pregnancy prevention 2Health News:Women who get dental care have lower risk of heart disease, says study 2Health News:Women who get dental care have lower risk of heart disease, says study 3Health News:New Clues to Treating Ovarian Cancer Relapse 2Health News:New Clues to Treating Ovarian Cancer Relapse 3Health News:Short and long sleep in early pregnancy linked to high blood pressure in the third trimester 2Health News:Short and long sleep in early pregnancy linked to high blood pressure in the third trimester 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: